# Embark Veterinary

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/embark-veterinary

- Industry: Biotechnology
- Headquarters: Boston, US
- Website: www.embarkvet.com
- Total disclosed funding: $91M
- Latest round: Series B (Jul 26, 2021)
- Investors on record: 10

## About

Embark Veterinary, Inc. offers innovative canine genetic testing and health supplements, specializing in enhancing dog health through comprehensive DNA analysis and wellness products.Founded in 2015 in Boston, US, Embark Veterinary, Inc. focuses on canine genetic testing that helps dog owners understand their pets better. The company has successfully raised USD 75.00 mn in its Series B funding round on July 26, 2021, led by SB Investment Advisers, with participation from investors including F-Prime Capital, Freestyle VC, SV Angel, and Slow Ventures. The company has completed a total of 5 funding deals since its inception. Ryan Boyko serves as both the CEO and Founder of Embark Veterinary, Inc.Embark Veterinary, Inc. specializes in canine genetic testing and health supplements, offering a comprehensive suite of products designed to enhance the well-being of dogs. Their core offerings include the Breed + Health Dog DNA Test, which identifies over 350 dog breeds and provides insights into health traits and potential allergy risks, as well as the unique Relative Finder feature that connects dogs with their genetic relatives in a vast database. Other products include the Breed ID DNA Test, which decodes a dog's breed mix and ancestry, and various health supplements that support canine health, including those targeting joint health and allergies. These products are primarily sold directly to consumers in the United States, with a growing customer base that includes pet owners seeking to better understand their dogs’ genetic backgrounds and health needs.Embark generates revenue through direct-to-consumer sales of its DNA tests and health supplements. The primary transaction structure consists of one-time purchases of individual products, with flagship offerings priced at USD 99.00 for the Breed ID DNA Test and USD 139.00 for the Breed + Health Dog DNA Test. Health supplements are also available, with prices starting at USD 34.99. The company leverages ecommerce platforms, allowing customers to conveniently order products online with the promise of free shipping on U.S. orders. This transactional model is designed to foster customer loyalty by providing valuable genetic insights and health solutions, which in turn encourages repeat purchases and customer retention.Embark Veterinary, Inc. plans to utilize the recently raised USD 75.00 mn in Series B funding to expand its workforce and accelerate the development of its discovery engine. The company intends to launch new products aimed at enhancing canine health and genetic understanding, seeking to enter new geographic markets within the next two years, specifically targeting regions where pet ownership is increasing. This strategic approach aims to solidify their market presence and foster sustainable growth.

## Funding rounds

- Series B, Jul 26, 2021, $75M — F-Prime Capital, SV Angel, Freestyle VC, Slow, Third Kind Venture Capital, SB Investment Advisers
- Series A, Apr 4, 2019, $10M — F-Prime Capital, Freestyle VC, Slow, FJ Labs, Third Kind Venture Capital, Section 32
- Seed, Jul 18, 2017, $4.5M — SV Angel, Founder Collective, Freestyle VC, Third Kind Venture Capital, Section 32
- Seed, May 31, 2016, $1.8M — Slow, AGO Partners
- Seed, Nov 2, 2015 — Slow, AGO Partners

## Investors

- Slow (https://capitalatlas.ai/funds/slow) — Seed, Series A, Series B
- AGO Partners (https://capitalatlas.ai/funds/ago-partners) — Seed
- SV Angel (https://capitalatlas.ai/funds/sv-angel) — Seed, Series B
- Founder Collective (https://capitalatlas.ai/funds/founder-collective) — Seed
- Freestyle VC (https://capitalatlas.ai/funds/freestyle-vc) — Seed, Series A, Series B
- Third Kind Venture Capital (https://capitalatlas.ai/funds/third-kind-venture-capital) — Seed, Series A, Series B
- Section 32 (https://capitalatlas.ai/funds/section-32) — Seed, Series A
- F-Prime Capital (https://capitalatlas.ai/funds/f-prime-capital) — Series A, Series B
- FJ Labs (https://capitalatlas.ai/funds/fj-labs) — Series A
- SB Investment Advisers (https://capitalatlas.ai/funds/sb-investment-advisers) — Series B